Infection and Corneal disorder


Corneal disorder is found among people with Infection, especially for people who are male, 60+ old.

The study analyzes which people have Corneal disorder with Infection. It is created by eHealthMe based on reports of 15 people who have Infection from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Apr, 01, 2023

15 people who have Infection and Corneal Disorder are studied.

What is Infection?

Infection is found to be associated with 2,899 drugs and 2,556 conditions by eHealthMe.

What is Corneal disorder?

Corneal disorder is found to be associated with 736 drugs and 418 conditions by eHealthMe.

Number of Corneal disorder in Infection reports submitted per year:

Would you have Corneal disorder when you have Infection?

Gender of people who have Infection and experienced Corneal Disorder *:

  • female: 41.67 %
  • male: 58.33 %

Age of people who have Infection and experienced Corneal Disorder *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 9.09 %
  • 40-49: 9.09 %
  • 50-59: 9.09 %
  • 60+: 72.73 %

Common co-existing conditions for these people *:

  1. Mydriasis (a dilation of the pupil): 3 people, 20.00%
  2. Rashes (redness): 1 person, 6.67%
  3. Itching: 1 person, 6.67%
  4. Herpes Simplex (herpes simplex is a common viral infection): 1 person, 6.67%
  5. Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 6.67%
  6. Eye Inflammation: 1 person, 6.67%
  7. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 6.67%
  8. Conjunctivitis Allergic (inflammation of the conjunctiva due to allergy): 1 person, 6.67%

Common drugs taken by these people *:

  1. Nevanac: 4 people, 26.67%
  2. Bss Plus: 2 people, 13.33%
  3. Vitamin D3: 1 person, 6.67%
  4. Latanoprost: 1 person, 6.67%
  5. Brimonidine: 1 person, 6.67%
  6. Bromfenac Sodium: 1 person, 6.67%
  7. Cefuroxime: 1 person, 6.67%
  8. Dupixent: 1 person, 6.67%
  9. Hyzaar: 1 person, 6.67%
  10. Magnesium: 1 person, 6.67%

Common symptoms for these people *:

  1. Visual Acuity Reduced (reduced clearness of vision): 5 people, 33.33%
  2. Corneal Oedema (corneal swelling): 5 people, 33.33%
  3. Eye Pain: 4 people, 26.67%
  4. Vision Blurred: 2 people, 13.33%
  5. Posterior Capsule Rupture (tear in the posterior capsule identified at the time of surgery): 2 people, 13.33%
  6. Corneal Opacity (scarring or clouding of the cornea): 2 people, 13.33%
  7. Foreign Body Sensation In Eyes (feeling of something in eye): 2 people, 13.33%
  8. Corneal Degeneration (abnormal deposition of substances in the transparent front part of the eye): 2 people, 13.33%
  9. Wound Dehiscence (a surgical incision reopens either internally or externally): 1 person, 6.67%
  10. Corneal Epithelium Defect (outer layer defect of cornea): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Corneal disorder?

Check whether Corneal disorder is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Corneal disorder:

All the drugs that are associated with Corneal disorder:

Common conditions associated with Corneal disorder:

All the conditions that are associated with Corneal disorder:

How the study uses the data?

The study is based on Corneal disorder and Infection, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: